Clinical Trials Logo

Clinical Trial Summary

The usage of splash basins in the setting of total knee arthroplasty and total hip arthroplasty presents a risk of contamination and subsequent periprosthetic joint infection. Previous studies have investigated the efficacy of multiple antimicrobial irrigants for preventing periprosthetic joint infection, but the results are varied. Despite several noteworthy studies on the appropriate usage of different antiseptic solutions in surgical splash basins, the current literature has several limitations. First, there are no head-to-head clinical trials comparing betadine and chlorhexidine gluconate (CHG) usage with relation to periprosthetic joint infection and splash basin contamination rates. Second, the in vitro studies directly cultured splash basin antiseptic solutions rather than culturing surgical instruments. The objective of this study is to compare the microbial contamination rate of total joint arthroplasty instruments that have been placed in surgical splash basins filled with either sterile water, 3.5% betadine, or 0.05% CHG. The overall purpose of the study is to investigate the efficacy of 0.05% CHG and determine if it is an appropriate solution to use in surgical splash basins for joint replacement surgeries. A prospective clinical trial will be conducted. Patients treated at the Keck Hospital of USC or USC Verdugo Hills Hospital for primary total hip or total knee arthroplasty will be screened for inclusion in our study. All primary surgeries will be performed according to the preferences of the operating surgeon. No deviations from standard surgical care will be made based on inclusion in this study. However, prior to surgery, patients who elect to participate will be randomized to one of three groups: (1) sterile water, (2) 3.5% betadine, or (3) 0.05% CHG.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04274517
Study type Interventional
Source University of Southern California
Contact
Status Terminated
Phase N/A
Start date January 16, 2021
Completion date June 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT02530229 - Arthrocentesis Study N/A
Recruiting NCT06126614 - Infection Prophylaxis in Total Joint Replacement Phase 3
Enrolling by invitation NCT05640336 - Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression N/A
Completed NCT03139539 - Intraoperative Microbial Contamination N/A
Recruiting NCT06268795 - A Diagnostic Test Accuracy Study Comparing Biopsy to Aspiration in Shoulder and Elbow Arthroplasty Revision Surgery (BASE Study)
Recruiting NCT05357287 - Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection N/A
Active, not recruiting NCT05084378 - Evaluation of Emerging New Treatments for Infection Prevention in Total Joint Replacement Phase 3
Recruiting NCT02868736 - Clinical Validation of CD Diagnostics Synovasure PJI ELISA Test and Synovasure PJI Lateral Flow Test for Detection of Periprosthetic Joint Infection in Synovial Fluid N/A
Not yet recruiting NCT06464770 - Optimizing Infection Prophylaxis Prior to Shoulder Surgery N/A
Recruiting NCT05284318 - Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
Not yet recruiting NCT06428448 - Study to Evaluate the REMEDY SPECTRUM IM Spacer Nail in the Treatment of Ankle-Related Infections Phase 2
Not yet recruiting NCT06189885 - Preoperative Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial N/A
Enrolling by invitation NCT05320354 - Diagnosis and Bacterial Identification of Periprosthetic Joint Infection With Microbial-ID
Recruiting NCT05495815 - Proper Duration of Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention N/A